Showing 1 - 4 results of 4 for search 'Giuseppe Spadola', query time: 0.03s Refine Results
  1. 1
    Mould-based surface high-dose-rate brachytherapy for eyelid carcinoma

    Mould-based surface high-dose-rate brachytherapy for eyelid carcinoma by Andrea Vavassori, Giulia Riva, Stefano Durante, Cristiana Fodor, Stefania Comi, Raffaella Cambria, Federica Cattani, Giuseppe Spadola, Roberto Orecchia, Barbara Jereczek-Fossa

    Published 2019-10-01
    Get full text
    Article
  2. 2
    Sunny holidays before and after melanoma diagnosis are respectively associated with lower Breslow thickness and lower relapse rates in Italy.

    Sunny holidays before and after melanoma diagnosis are respectively associated with lower Breslow thickness and lower relapse rates in Italy. by Sara Gandini, Esther De Vries, Giulio Tosti, Edoardo Botteri, Giuseppe Spadola, Patrick Maisonneuve, Chiara Martinoli, Arjen Joosse, Pier Francesco Ferrucci, Federica Baldini, Emilia Cocorocchio, Elisabetta Pennacchioli, Francesco Cataldo, Barbara Bazolli, Alessandra Clerici, Massimo Barberis, Veronique Bataille, Alessandro Testori

    Published 2013-01-01
    Get full text
    Article
  3. 3
    Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial

    Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial by Harriet Johansson, Giuseppe Spadola, Giulio Tosti, Mario Mandalà, Alessandro M. Minisini, Paola Queirolo, Valentina Aristarco, Federica Baldini, Emilia Cocorocchio, Elena Albertazzi, Leonardo Zichichi, Saverio Cinieri, Costantino Jemos, Giovanni Mazzarol, Patrizia Gnagnarella, Debora Macis, Ines Tedeschi, Emanuela Omodeo Salè, Luigia Stefania Stucci, Bernardo Bonanni, Alessandro Testori, Elisabetta Pennacchioli, Pier Francesco Ferrucci, Sara Gandini, on behalf of the Italian Melanoma Intergroup (IMI)

    Published 2021-06-01
    Get full text
    Article
  4. 4
    Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in <em>ACD</em>, <em>ATM</em>, <em>BAP1</em>, and <em>POT1</em>

    Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in <em>ACD</em>, <em>ATM</em>, <em>BAP1</em>, and <em>POT1</em> by Lorenza Pastorino, Virginia Andreotti, Bruna Dalmasso, Irene Vanni, Giulia Ciccarese, Mario Mandalà, Giuseppe Spadola, Maria Antonietta Pizzichetta, Giovanni Ponti, Maria Grazia Tibiletti, Elena Sala, Maurizio Genuardi, Pietro Chiurazzi, Gabriele Maccanti, Siranoush Manoukian, Serena Sestini, Rita Danesi, Valentina Zampiga, Roberta La Starza, Ignazio Stanganelli, Alberto Ballestrero, Luca Mastracci, Federica Grillo, Stefania Sciallero, Federica Cecchi, Enrica Teresa Tanda, Francesco Spagnolo, Paola Queirolo, Italian Melanoma Intergroup (IMI), Alisa M. Goldstein, William Bruno, Paola Ghiorzo

    Published 2020-04-01
    Get full text
    Article

Search Tools: